Kuangli Bio-Tech Holdings Co (TPE:6431) Return-on-Tangible-Equity: -69.95% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6431 Kuangli Bio-Tech Holdings Co Ltd TPE:6431
66 GF Score
Price NT$18.35
GF Value NT$11.68
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Kuangli Bio-Tech Holdings Co Return-on-Tangible-Equity?

Kuangli Bio-Tech Holdings Co TPE:6431 +0.27% 66 Return-on-Tangible-Equity is -69.95% as of Dec. 2025. GuruFocus rates TPE:6431 with a GF Score™ of 66/100 and a GF Value™ of NT$11.68 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,879 Consumer Packaged Goods companies, Kuangli Bio-Tech Holdings Co ranks worse than 95.37% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Kuangli Bio-Tech Holdings Co's annualized net income for the quarter that ended in Dec. 2025 was NT$-243.6 Mil. Kuangli Bio-Tech Holdings Co's average shareholder tangible equity for the quarter that ended in Dec. 2025 was NT$348.3 Mil. Therefore, Kuangli Bio-Tech Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was -69.95%.

The historical rank and industry rank for Kuangli Bio-Tech Holdings Co's Return-on-Tangible-Equity or its related term are showing as below:

TPE:6431' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -77.4   Med: -29.86   Max: 11.38
Current: -55.11

During the past 13 years, Kuangli Bio-Tech Holdings Co's highest Return-on-Tangible-Equity was 11.38%. The lowest was -77.40%. And the median was -29.86%.

TPE:6431's Return-on-Tangible-Equity is ranked worse than
95.37% of 1879 companies
in the Consumer Packaged Goods industry
Industry Median: 7.78 vs TPE:6431: -55.11

Kuangli Bio-Tech Holdings Co  (TPE:6431) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Kuangli Bio-Tech Holdings Co Return-on-Tangible-Equity Related Terms


Kuangli Bio-Tech Holdings Co Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Kuangli Bio-Tech Holdings Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kuangli Bio-Tech Holdings Co Return-on-Tangible-Equity Chart

Kuangli Bio-Tech Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.38 -28.46 -34.58 -77.40 -74.34

Kuangli Bio-Tech Holdings Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -118.27 -43.70 -49.33 -44.89 -69.95

TPE:6431 vs PG, CL, KVUE: Return-on-Tangible-Equity Comparison

For the Household & Personal Products subindustry, Kuangli Bio-Tech Holdings Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kuangli Bio-Tech Holdings Co Return-on-Tangible-Equity vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kuangli Bio-Tech Holdings Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Kuangli Bio-Tech Holdings Co's Return-on-Tangible-Equity falls into.


TPE:6431
66GF Score
Kuangli Bio-Tech Holdings Co Ltd TPE:6431
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kuangli Bio-Tech Holdings Co Return-on-Tangible-Equity Calculation

Kuangli Bio-Tech Holdings Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-192.977/( (186.796+332.381 )/ 2 )
=-192.977/259.5885
=-74.34 %

Kuangli Bio-Tech Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=-243.612/( (364.189+332.381)/ 2 )
=-243.612/348.285
=-69.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of -69.95% mean?
Kuangli Bio-Tech Holdings Co (TPE:6431) has a Return-on-Tangible-Equity of -69.95% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. According to the industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #1792 out of 1879 companies in the Consumer Packaged Goods industry, placing it in the top 95.4%.
Is Kuangli Bio-Tech Holdings Co's Return-on-Tangible-Equity too high?
Kuangli Bio-Tech Holdings Co's current Return-on-Tangible-Equity is -69.95%. Based on the distribution chart, Kuangli Bio-Tech Holdings Co ranks #1792 out of 1879 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's Return-on-Tangible-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #1792 out of 1879 companies for Return-on-Tangible-Equity. This places Kuangli Bio-Tech Holdings Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.78, based on 1,879 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kuangli Bio-Tech Holdings Co's current Return-on-Tangible-Equity is -69.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$11.68, compared to a current price of NT$18.35 — trading 57.1% above its estimated fair value. The current Return-on-Tangible-Equity is -69.95%. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current Return-on-Tangible-Equity is -69.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?

Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued. The current stock price of NT$18.35 is trading 57.1% above its estimated GF Value™ of NT$11.68. GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.

Key valuation signals for TPE:6431:

  • Return-on-Tangible-Equity: -69.95%
  • GF Value™: NT$11.68 vs. price of NT$18.35 (57.1% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kuangli Bio-Tech Holdings Co Business Description

Address North Sound Road, Suite 102, Cannon Place, George Town, Grand Cayman, CYM
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
66GF Score

Get the complete analysis for TPE:6431

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.35
Price
NT$11.68
GF Value